Craig Bijou
Stock Analyst at B of A Securities
(3.84)
# 725
Out of 4,734 analysts
59
Total ratings
61.29%
Success rate
64.52%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Upgrades: Neutral | $80 → $97 | $90.80 | +6.83% | 4 | Jan 9, 2025 | |
| BLCO Bausch + Lomb | Reinstates: Underperform | $18 | $17.36 | +3.69% | 2 | Dec 12, 2024 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $24.10 | -25.31% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $141.00 | +2.84% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $102.90 | +0.10% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $73.49 | +15.66% | 1 | Sep 11, 2024 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $80 → $94 | $76.02 | +23.65% | 3 | Aug 22, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $84.74 | +1.49% | 2 | May 1, 2024 | |
| COO The Cooper Companies | Initiates: Buy | $95 | $93.27 | +1.85% | 1 | Oct 30, 2023 | |
| TFX Teleflex | Maintains: Neutral | $265 | $181.27 | +46.19% | 4 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $25 | $10.88 | +129.78% | 1 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $16.69 | +115.70% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $8.40 | +435.71% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1 → $8 | $0.65 | +1,127.94% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $15.90 | +88.68% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $10.23 | +27.08% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $18.13 | +131.66% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $592.64 | -61.19% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $383.42 | -40.01% | 4 | Jul 26, 2019 |
Globus Medical
Jan 9, 2025
Upgrades: Neutral
Price Target: $80 → $97
Current: $90.80
Upside: +6.83%
Bausch + Lomb
Dec 12, 2024
Reinstates: Underperform
Price Target: $18
Current: $17.36
Upside: +3.69%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $24.10
Upside: -25.31%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $141.00
Upside: +2.84%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $102.90
Upside: +0.10%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $73.49
Upside: +15.66%
PROCEPT BioRobotics
Aug 22, 2024
Maintains: Buy
Price Target: $80 → $94
Current: $76.02
Upside: +23.65%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $84.74
Upside: +1.49%
The Cooper Companies
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $93.27
Upside: +1.85%
Teleflex
Aug 3, 2023
Maintains: Neutral
Price Target: $265
Current: $181.27
Upside: +46.19%
Mar 9, 2022
Maintains: Buy
Price Target: $30 → $25
Current: $10.88
Upside: +129.78%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $16.69
Upside: +115.70%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $8.40
Upside: +435.71%
Mar 25, 2020
Maintains: Overweight
Price Target: $1 → $8
Current: $0.65
Upside: +1,127.94%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $15.90
Upside: +88.68%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $10.23
Upside: +27.08%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $18.13
Upside: +131.66%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $592.64
Upside: -61.19%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $383.42
Upside: -40.01%